Name: NeuroOne Medical Technologies Corporation (NMTC) Cash Flow Statement
Creator: FinSpry

NeuroOne Medical Technologies Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scale:

Scroll to see more

Cash flow statement showing operating, investing, and financing activities for NeuroOne Medical Technologies Corporation (NMTC) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 2025	Sep 2024	Sep 2023	Sep 2022	Sep 2021
Operating Activities
Net Income	-3.61	-12.32	-11.86	-10.00	-9.95
Depreciation & Amortization	0.26	0.25	0.15	0.12	0.08
Stock Based Compensation	1.26	1.34	1.11	0.95	1.79
Change in Working Capital	0.00	-0.95	-2.43	1.21	-0.51
Change in Accounts Receivable	-1.09	-0.18	0.03	0.02	-0.05
Change in Inventory	0.01	-0.91	-1.02	-0.61	-0.10
Change in Accounts Payable	0.24	0.07	-0.25	0.52	-0.35
Change in Other Working Capital	0.00	0.67	0.11	1.29	-0.02
Other Operating Activities	-0.76	0.67	1.22	0.21	1.78
Net Cash from Operating Activities	-2.84	-11.01	-12.89	-7.52	-8.60
Investing Activities
Capital Expenditures	-0.08	-0.12	0.38	-0.28	0.07
Purchases of Investments	0.00	0.00	-1.47	-2.97	0.00
Sales/Maturities of Investments	0.00	0.00	3.03	0.50	0.00
Net Cash from Investing Activities	-0.08	-0.12	2.65	-3.24	-0.07
Financing Activities
Common Stock Issued	9.61	5.87	8.59	13.35	9.11
Common Stock Repurchased	0.00	-0.08	-0.12	0.00	0.00
Other Financing Activities	0.14	-0.33	7.40	-1.33	7.58
Net Cash from Financing Activities	0.14	7.27	7.40	12.02	11.53
Summary
Net Change in Cash	5.11	-3.86	-2.84	1.26	2.86
Cash at Beginning of Period	1.46	5.32	8.16	6.90	4.04
Cash at End of Period	6.57	1.46	5.32	8.16	4.04
Free Cash Flow	-2.92	-11.13	-13.26	-7.79	-8.67